Analysis of the side effects and treatment methods of afatinib (Gitari)

Afatinib (Afatinib) is an irreversible ErbB family receptor tyrosine kinase inhibitor (TKI), which is widely used in the treatment of EGFR mutant non-small cell lung cancer (NSCLC) and other diseases. The drug inhibits the proliferation and growth of tumor cells by blocking signaling pathways such as EGFR, HER2 and HER4. Although afatinib has shown good clinical efficacy, like all targeted drugs, it also has certain side effects. Correctly understanding these adverse reactions and adopting scientific management strategies are of great significance for improving treatment compliance, extending treatment courses, and improving patients' quality of life.

1. Common side effects and mechanisms

1.Skin rash and dry skin

Skin rash is one of the most common adverse reactions of afatinib, with an incidence rate of more than 70%. It usually manifests as erythema, papules, itching or dry scaling on the face, chest and back. The mechanism is mainly related to the inhibition of the EGFR signaling pathway in skin epithelial cells, resulting in abnormal keratinocyte differentiation and reduced sebaceous gland secretion.

2.Diarrhea

Diarrhea usually occurs during the initial treatment period and is one of the most significant dose-limiting side effects of afatinib. Research shows that approximately 40%of patients will experience varying degrees of diarrhea, and some patients may experience moderate to severe symptoms. The mechanism is related to the inhibitory effect of drugs on intestinal epithelial cellsEGFR receptors, resulting in damage to the intestinal mucosal barrier and impairment of water and electrolyte absorption.

3.Stomatitis and mucositis

Oral mucosal ulcers or pain are common within 2 to 4 weeks of medication and are mostly mild to moderate. EGFR plays an important role in mucosal repair. After being inhibited, the regeneration ability of mucosal epithelium is reduced, so inflammation and ulceration are prone to occur.

4.Paronychia and nail changes

Long-term use may lead to paronychia, nail thickening or brittleness, mainly due to impaired skin barrier function and bacterial and fungal infections. Although not life-threatening, it often affects patients' daily activities and mental state.

5.Loss of appetite and weight loss

Some patients will experience loss of appetite, changes in taste, and weight loss, which are usually related to diarrhea, stomatitis, and mild effects of drugs on the metabolic system.

6.Abnormal liver function and interstitial lung disease (ILD)

A few patients may experience elevated transaminases or abnormal bilirubin, and liver function needs to be monitored regularly. Although interstitial lung disease is rare (incidence<1%), once dyspnea, dry cough or fever occurs, you should stop taking the drug and seek medical advice immediately.

2. Strategies for coping with side effects of varying degrees

1. Treatment of rash and adverse skin reactions

Mild (1~2 grade): It is recommended to use moisturizing cream every day and avoid sun exposure and hot water bathing; topical weak glucocorticoids (such as hydrocortisone cream) can relieve inflammation.

Moderate (Grade 2~3): Oral antihistamines (such as loratadine) or short-term oral low-dose antibiotics (such as doxycycline) can be combined, while keeping the skin clean and dry.

Severe (≥3 grade): Suspend afatinib treatment and resume use when symptoms improve to 1 or below. Dosage reduction may be considered.

2.Diarrhea treatment

Mild: Replenish water and electrolytes in time, and take oral loperamide (Loperamide) to control symptoms.

Moderate or above: Close monitoring of dehydration, electrolyte imbalance, etc. is required. If there is no improvement for more than 48 consecutive hours, the medication should be suspended and intravenous rehydration treatment should be performed.

Dietary advice: Avoid greasy, spicy foods and dairy products, and adopt a light and easy-to-digest diet.

3.Management of stomatitis and mucositis

Rinse your mouth with warm salt water every day and avoid using alcohol-based mouthwash;

Topical oral mucosal repair agents or local anesthetics can be used to relieve pain;

Maintain good oral hygiene and avoid spicy and irritating foods.

4.Paronychia and nail problems

Trim nails regularly and keep hands and feet clean;

Antibacterial ointment or diluted iodophor solution can be used locally;

For severe pain, you can apply local heat or consult a dermatologist for treatment.

5. Monitoring and treatment of abnormal liver function

Monitor liver function initially and at the end of each course of treatment;

If there is a significant increase in ALT or AST, the medication should be suspended and the dose should be adjusted according to the situation;

Severe liver injury requires discontinuation of the drug and hepatoprotective treatment.

6.Interstitial lung disease warning

If the patient develops unexplained difficulty breathing, dry cough, or fever, the medication should be stopped immediately and a chest CT examination should be performed;

Once confirmed, glucocorticoid therapy should be given and afatinib should be permanently discontinued.

3. Dose adjustment and patient education

The standard starting dose of afatinib is usually 40 mg once daily. For patients who experience ≥ grade 3 adverse reactions or are intolerant, the dose can be gradually reduced in steps of 10 mg (to 30 mg or 20 mg/ days). Reducing the dose will not significantly reduce efficacy, but can significantly improve tolerability.

Additionally, patient education is equally critical:

1. Maintain good living habits during medication and avoid strong sun exposure and spicy food;

2. Regularly review blood routine, liver and kidney function;

3.If persistent diarrhea or rash occurs, the doctor should be informed in time and it is not advisable to stop taking the medicine on your own;

4.Female patients should pay attention to contraception and avoid pregnancy during treatment and for at least one month after stopping the drug.

Overall, afatinib is a targeted therapy with definite efficacy, and most of its side effects are controllable and reversible. Through early identification, active intervention and individualized dose adjustment, most patients can successfully complete treatment and maintain a good quality of life. Close communication and continuous monitoring between doctors and patients are key to ensuring the safe and effective use of afatinib.

Reference materials:https://www.drugs.com/

xa0